中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2015年
16期
83-85
,共3页
次大面积肺栓塞%抗凝治疗%伊洛前列素
次大麵積肺栓塞%抗凝治療%伊洛前列素
차대면적폐전새%항응치료%이락전렬소
Sub massive pulmonary embolism%Anticoagulant therapy%Liloprost
目的：评价伊洛前列素联合抗凝治疗次大面积肺栓塞患者的疗效。方法2011年5月~2013年5月我院收治次大面积肺栓塞患者12例,常规予抗凝治疗后应用伊洛前列素(2.5~5.0)μg/15 min,每日6次吸入。对比吸入前后患者超声心动图、血氧饱和度、心率、呼吸频率、肺功能(PEF、FEV1、FVC、FEF、FEVE、MVV)。结果吸入伊洛前列素后,各项观测指标较吸入前相比均有不同程度的改善,与吸入前相比,除PEF和FEF两项外,差异均具有统计学意义(P<0.05)。结论伊洛前列素联合抗凝治疗能够有效改善次大面积肺栓塞患者右心功能。
目的：評價伊洛前列素聯閤抗凝治療次大麵積肺栓塞患者的療效。方法2011年5月~2013年5月我院收治次大麵積肺栓塞患者12例,常規予抗凝治療後應用伊洛前列素(2.5~5.0)μg/15 min,每日6次吸入。對比吸入前後患者超聲心動圖、血氧飽和度、心率、呼吸頻率、肺功能(PEF、FEV1、FVC、FEF、FEVE、MVV)。結果吸入伊洛前列素後,各項觀測指標較吸入前相比均有不同程度的改善,與吸入前相比,除PEF和FEF兩項外,差異均具有統計學意義(P<0.05)。結論伊洛前列素聯閤抗凝治療能夠有效改善次大麵積肺栓塞患者右心功能。
목적：평개이락전렬소연합항응치료차대면적폐전새환자적료효。방법2011년5월~2013년5월아원수치차대면적폐전새환자12례,상규여항응치료후응용이락전렬소(2.5~5.0)μg/15 min,매일6차흡입。대비흡입전후환자초성심동도、혈양포화도、심솔、호흡빈솔、폐공능(PEF、FEV1、FVC、FEF、FEVE、MVV)。결과흡입이락전렬소후,각항관측지표교흡입전상비균유불동정도적개선,여흡입전상비,제PEF화FEF량항외,차이균구유통계학의의(P<0.05)。결론이락전렬소연합항응치료능구유효개선차대면적폐전새환자우심공능。
Objective To evaluate the effection of iloprost combined with anticoagulant drugs on the patients of sub massive pulmonary embolism. Methods Twelve sub massive pulmonary embolism patients from May 2011 to May 2013 in our hospital were treated by conventional anticoagulant therapy and inhalation of iloprost [(2.5-5.0)μg/15 min, 6 times per day]. To compare the change on the ultrasonic cardiogram, oxyhemoglobin saturation, heart rate, breathing rate, pulmonary function (PEF, FEV1, FVC, FEF, FEVE, MVV) between pre-inhalation of iloprost and post-inhalation of iloprost. Results All clinical data were improved compared with pre-inhalation of iloprost post- inhalation of iloprost,compared with before inhalation, except for PEF and FEF, the differences were statistically signicant (P<0.05). Con-clusion Inhaled iloprost combined with anticoagulant drugs can markedly improved the right ventricular dysfunction in the patients of sub massive pulmonary embolism.
